What's Next for CRISPR Gene-Editing Therapies?

What's Next for CRISPR Gene-Editing Therapies?
(AP Photo/Jeff Chiu, Pool)

When last year’s Nobel prize for chemistry was awarded to biochemist Jennifer Doudna and microbiologist Emmanuelle Charpentier for their work in developing the technique of gene editing known as Crispr-Cas9 (pronounced “crisper”), headlines hailed their discovery as “molecular scissors” that would allow us to “rewrite the book of life” – with all the complicated ethical questions that ability raises.

Read Full Article »


Comment
Show comments Hide Comments


Related Articles